Source: Drug Store News

Civica: Biocon Biologics, Civica collaborate to expand insulin Aspart access

Biocon Biologics will supply Insulin Aspart drug substance to Civica, who will use the drug substance to produce Insulin Aspart drug product.

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Lee Perkins's photo - CEO of Civica

CEO

Lee Perkins

CEO Approval Rating

84/100

Read more